[The physiological basis of the treatment of tumor lysis syndrome].
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Factors, which affected the stability of peroxisomal membrane in vitro, were investigated. The decrease in the activity of catalase at neutral and alkaline pH was prevented by addition of Ca2+, Mg2+ and Ba2+; at the same time EDTA, EGTA and o-phenantroline decreased the stability of peroxisomes. All the effects were temperature-dependent. Ca2+ did not prevent the injury of peroxisomes during hypotonic lysis, but increased the electrostatic interactions of enzymes with the peroxisomal membrane. These data suggest that at neutral and alkaline pH the peroxisomal membranes had a large negative charge on their surface, which affected the stability of peroxisomes in vitro.
Because of the discovery of uric acid urolithiasis in rats after end-to-side portacaval anastomosis (PCA), uric acid metabolism was studied in these animals and in appropriate controls. Hyperuricemia and hyperuricosuria were observed in all experimental rats. The fraction of purine catabolites excreted in the urine as uric acid increased from an average of 4.8% to 15.3%. If 14C-uric specifically labeled at position 6 (6-14C-ua) was infused intravenously and the exhalation of 14CO2 was used to calculate a hepatic uric acid clearance, it decreased from 2.14 to 0.97 ml/min/100 gm despite a normal content of hepatic uricase activity as measured in liver homogenates. The fraction of the filtered amount of uric acid excreted in the urine increased from an average of 11% to 30%. Increased supersaturation of the urine with uric acid after PCA may be expected to contribute to the formation of uric acid urolithiasis. This investigation defines a hepatic and renal functional defect in uric acid metabolism which occurs as a result of the PCA.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
SFBC work group on uric acid propose a method for evaluation in blood serum which is modeled on the one defined by American Association for Clinical Chemistry. Serum is deproteinized by trichoracetic acid and the supernatant, buffered to pH 8.5, is submitted to uricase action. The disappearing of the strong band of uric acid in UV is measured by derivative spectrophotometry; this procedure vanished the effect of trouble which remains in the supernatant. This spectrophotometric technic permit to reach, in multiple sites, a variation coefficient near of 1 p. cent.
A uricase producing strain, Candida utilis AS 2.117, was screened out and the uricase-forming conditions have been investigated. The results are obtained as follows: uric acid, xanthine and guanine were found to be effective inducers for enzyme formation. Corn steep liquor was essential for enzyme formation and cell growth. Sucrose, glucose, D-mannose and D-fructose were the suitable carbon sources for enzyme formation. To the medium containing corn steep liquor, addition of inorganic nitrogen sources was harmful to the enzyme formation, however, addition of organic nitrogen sources enhanced enzyme activity slightly. The suitable medium for uricase formation was consisted of sucrose 5%, corn steep liquor 3%, uric acid 0.1%, proteose-peptone 0.1%, biotin 0.05%, KCl 0.1%, NaCl 0.1% at pH 6.2. When the yeast was grown in 250 ml conic flask containing 30 ml of the medium mentioned above on the rotary shaker (200 r/min) at 25 degrees C for 21 h, uricase with 0.6 u/ml activity was obtained.
The performance of the Reflotron system (Boehringer Mannheim) for the determination of urate in whole blood and serum was evaluated. Within-run and day-to-day imprecision of the system were comparable with those for a solution-chemistry enzymatic method (overall CVs in the range 2.2-2.5%). Results for 100 individual specimens with urate concentrations ranging from 16 to 134 mg/L agreed well with the comparison method, both for serum and whole blood. We saw no significant interference from lipemia or hemoglobin. Bilirubin interfered at concentrations greater than 100 mg/L. Hematocrit variation between 25% and 55% did not affect results for whole blood; variation of the applied sample volume from 28 microL to 35 microL (stated sample volume requirement: 30 microL) did not significantly influence the measured value. We consider results produced by the system to be of the same analytical quality as those obtained by the more conventional solution-chemistry methods that are currently available.
Explore the source record for details and available documents.
We have isolated cDNA clones for rat liver uricase using an oligonucleotide corresponding to the N-terminal sequence of 8 amino acids. The nucleotide sequences of the cDNAs have been determined, and the amino acid sequence of the protein deduced. A 867-base open reading frame coding for 289 amino acids, corresponding to a molecular mass of 33,274 daltons, was confirmed by matching eight sequences of a total of 53 amino acids from peptide sequence analyses of the fragments generated by lysyl endopeptidase digestion of purified rat liver uricase. The deduced amino acid sequence of rat liver uricase shares 40% homology with that of soybean nodulin-specific uricase and has an N-terminal extension of 7 amino acids. In contrast, soybean uricase has a C-terminal extension of 12 amino acids, which is presumably the result of local gene duplication. Completely different N- and C-terminal structures of the two uricases suggest that the signals for targeting the proteins to the peroxisome are not located on the terminal continuous stretches of amino acids.
Explore the source record for details and available documents.
A 62-year-old woman receiving chemotherapy with etoposide showed discrepant uric acid values as measured by a direct phosphotungstic acid (PTA) method (150 mg/L) compared with a uricase technique (40 mg/L). After ultrafiltration, the positive interference for the direct PTA method was retained in the protein fraction, but not in the filtrate. Adding exogenous etoposide to drug-free serum confirmed this interference for the direct PTA method, but not for the uricase procedure or a PTA technique preceded by dialysis. Decisions for aggressive patient management are often based on the magnitude of hyperuricemia. We do not recommend that the direct phosphotungstic acid method be used to measure uric acid in patients receiving etoposide.
Explore the source record for details and available documents.
Explore the source record for details and available documents.